Ucb Sa Adr Stock Performance
UCBJY Stock | USD 63.31 0.31 0.49% |
On a scale of 0 to 100, UCB SA holds a performance score of 27. The firm owns a Beta (Systematic Risk) of 0.58, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, UCB SA's returns are expected to increase less than the market. However, during the bear market, the loss of holding UCB SA is expected to be smaller as well. Please check UCB SA's downside variance, and the relationship between the total risk alpha and daily balance of power , to make a quick decision on whether UCB SA's current price history will revert.
Risk-Adjusted Performance
27 of 100
Weak | Strong |
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in UCB SA ADR are ranked lower than 27 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak forward-looking indicators, UCB SA showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Begin Period Cash Flow | 1.3 B | |
Total Cashflows From Investing Activities | -487 M |
UCB |
UCB SA Relative Risk vs. Return Landscape
If you would invest 4,453 in UCB SA ADR on January 18, 2024 and sell it today you would earn a total of 1,878 from holding UCB SA ADR or generate 42.17% return on investment over 90 days. UCB SA ADR is currently producing 0.5731% returns and takes up 1.6407% volatility of returns over 90 trading days. Put another way, 14% of traded pink sheets are less volatile than UCB, and 89% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
Risk |
UCB SA Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for UCB SA's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as UCB SA ADR, and traders can use it to determine the average amount a UCB SA's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.3493
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | UCBJY | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
1.64 actual daily | 14 86% of assets are more volatile |
Expected Return
0.57 actual daily | 11 89% of assets have higher returns |
Risk-Adjusted Return
0.35 actual daily | 27 73% of assets perform better |
Based on monthly moving average UCB SA is performing at about 27% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of UCB SA by adding it to a well-diversified portfolio.
UCB SA Fundamentals Growth
UCB Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of UCB SA, and UCB SA fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on UCB Pink Sheet performance.
Return On Equity | 0.11 | |||
Return On Asset | 0.0468 | |||
Profit Margin | 0.15 % | |||
Operating Margin | 0.19 % | |||
Current Valuation | 16.62 B | |||
Shares Outstanding | 379.92 M | |||
Price To Earning | 17.55 X | |||
Price To Book | 1.55 X | |||
Price To Sales | 2.54 X | |||
Revenue | 5.78 B | |||
EBITDA | 1.6 B | |||
Cash And Equivalents | 515 M | |||
Cash Per Share | 1.36 X | |||
Total Debt | 1.97 B | |||
Debt To Equity | 0.34 % | |||
Book Value Per Share | 23.47 X | |||
Cash Flow From Operations | 1.55 B | |||
Earnings Per Share | 2.45 X | |||
Total Asset | 14.21 B | |||
Retained Earnings | 3 B | |||
Current Asset | 2.46 B | |||
Current Liabilities | 2.71 B | |||
About UCB SA Performance
To evaluate UCB SA ADR Pink Sheet as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when UCB SA generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare UCB Pink Sheet's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand UCB SA ADR market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents UCB's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases. The company was incorporated in 1925 and is headquartered in Brussels, Belgium. UCB S operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 8600 people.Things to note about UCB SA ADR performance evaluation
Checking the ongoing alerts about UCB SA for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for UCB SA ADR help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Evaluating UCB SA's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate UCB SA's pink sheet performance include:- Analyzing UCB SA's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether UCB SA's stock is overvalued or undervalued compared to its peers.
- Examining UCB SA's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating UCB SA's management team can have a significant impact on its success or failure. Reviewing the track record and experience of UCB SA's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of UCB SA's pink sheet. These opinions can provide insight into UCB SA's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UCB SA ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in inflation. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for UCB Pink Sheet analysis
When running UCB SA's price analysis, check to measure UCB SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UCB SA is operating at the current time. Most of UCB SA's value examination focuses on studying past and present price action to predict the probability of UCB SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UCB SA's price. Additionally, you may evaluate how the addition of UCB SA to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |